LIFE - Atyr Pharma Inc
0.7927
-0.007 -0.833%
Share volume: 786,745
Last Updated: 03-26-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$0.80
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-13-2024 | 11-07-2024 | 03-13-2025 | 05-07-2025 | 08-07-2025 | 11-06-2025 | 03-05-2026 | |
| Total revenue | 235.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 235.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 16.871 M | 17.315 M | 18.143 M | 15.820 M | 15.773 M | 20.313 M | 26.935 M | 14.796 M | |
| Selling general and admin | 3.507 M | 3.342 M | 3.336 M | 3.592 M | 3.959 M | 4.929 M | 4.805 M | 3.905 M | |
| Research and development | 13.364 M | 13.973 M | 14.807 M | 12.228 M | 11.814 M | 15.384 M | 22.130 M | 10.891 M | |
| Total expenses | 16.871 M | 17.315 M | 18.143 M | 15.820 M | 15.773 M | 20.313 M | 26.935 M | 14.796 M | |
| 2.63% | 4.78% | -12.80% | -0.30% | 28.78% | 32.60% | -45.07% | |||
| Operating income | -16.636 M | -17.315 M | -18.143 M | -15.820 M | -15.773 M | -20.313 M | -26.745 M | -14.796 M | |
| Ebit | -15.487 M | -16.306 M | -17.261 M | -15.820 M | -14.881 M | -19.532 M | -25.746 M | -13.964 M | |
| Pretax income | -15.487 M | -16.306 M | -17.261 M | -18.860 M | -14.881 M | -19.532 M | -25.746 M | -13.964 M | |
| 5.29% | 5.86% | 9.26% | -21.10% | 31.25% | 31.81% | -45.76% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -15.487 M | -16.306 M | -17.261 M | -14.969 M | -14.881 M | -19.532 M | -25.746 M | -13.964 M | |
| -5.29% | -5.86% | 13.28% | 0.59% | -31.25% | -31.81% | 45.76% |